Ethnic differences in the neuroleptic treatment of schizophrenia

Pedro Ruiz, Roy V. Varner, David R. Small, Bankole A. Johnson

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Ethnic differences in psychopharmacological treatment have received much attention in the last two decades. Most of the research efforts conducted so far in the field of ethnopsychopharmacology have focused on comparative responses to neuroleptics and lithium between white and Asian-American patients, and on comparative responses to tricyclic antidepressants among white, African-American and Hispanic patients. In this article we focus on the response to neuroleptic treatment among white, African-American and Hispanic patients suffering from schizophrenia. Our findings suggest that Hispanic patients need lower doses of neuroleptics than white or African- American patients to attain a similar response in the treatment of schizophrenia. Additionally, our study suggests that, if weight is taken to consideration, African-American patients need the same dose of neuroleptics as do white patients in order to attain a similar response in the treatment of schizophrenia. Further studies are suggested to confirm our findings.

Original languageEnglish
Pages (from-to)163-172
Number of pages10
JournalPsychiatric Quarterly
Volume70
Issue number2
DOIs
StatePublished - Jun 30 1999
Externally publishedYes

Fingerprint

Antipsychotic Agents
Schizophrenia
African Americans
Hispanic Americans
Therapeutics
Asian Americans
Tricyclic Antidepressive Agents
Lithium
Weights and Measures
Research

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Ruiz, P., Varner, R. V., Small, D. R., & Johnson, B. A. (1999). Ethnic differences in the neuroleptic treatment of schizophrenia. Psychiatric Quarterly, 70(2), 163-172. https://doi.org/10.1023/A:1022153403924

Ethnic differences in the neuroleptic treatment of schizophrenia. / Ruiz, Pedro; Varner, Roy V.; Small, David R.; Johnson, Bankole A.

In: Psychiatric Quarterly, Vol. 70, No. 2, 30.06.1999, p. 163-172.

Research output: Contribution to journalArticle

Ruiz, P, Varner, RV, Small, DR & Johnson, BA 1999, 'Ethnic differences in the neuroleptic treatment of schizophrenia', Psychiatric Quarterly, vol. 70, no. 2, pp. 163-172. https://doi.org/10.1023/A:1022153403924
Ruiz, Pedro ; Varner, Roy V. ; Small, David R. ; Johnson, Bankole A. / Ethnic differences in the neuroleptic treatment of schizophrenia. In: Psychiatric Quarterly. 1999 ; Vol. 70, No. 2. pp. 163-172.
@article{823490722a8f474dbdc186b9f29f569c,
title = "Ethnic differences in the neuroleptic treatment of schizophrenia",
abstract = "Ethnic differences in psychopharmacological treatment have received much attention in the last two decades. Most of the research efforts conducted so far in the field of ethnopsychopharmacology have focused on comparative responses to neuroleptics and lithium between white and Asian-American patients, and on comparative responses to tricyclic antidepressants among white, African-American and Hispanic patients. In this article we focus on the response to neuroleptic treatment among white, African-American and Hispanic patients suffering from schizophrenia. Our findings suggest that Hispanic patients need lower doses of neuroleptics than white or African- American patients to attain a similar response in the treatment of schizophrenia. Additionally, our study suggests that, if weight is taken to consideration, African-American patients need the same dose of neuroleptics as do white patients in order to attain a similar response in the treatment of schizophrenia. Further studies are suggested to confirm our findings.",
author = "Pedro Ruiz and Varner, {Roy V.} and Small, {David R.} and Johnson, {Bankole A.}",
year = "1999",
month = "6",
day = "30",
doi = "10.1023/A:1022153403924",
language = "English",
volume = "70",
pages = "163--172",
journal = "Psychiatric Quarterly",
issn = "0033-2720",
publisher = "Kluwer Academic/Human Sciences Press Inc.",
number = "2",

}

TY - JOUR

T1 - Ethnic differences in the neuroleptic treatment of schizophrenia

AU - Ruiz, Pedro

AU - Varner, Roy V.

AU - Small, David R.

AU - Johnson, Bankole A.

PY - 1999/6/30

Y1 - 1999/6/30

N2 - Ethnic differences in psychopharmacological treatment have received much attention in the last two decades. Most of the research efforts conducted so far in the field of ethnopsychopharmacology have focused on comparative responses to neuroleptics and lithium between white and Asian-American patients, and on comparative responses to tricyclic antidepressants among white, African-American and Hispanic patients. In this article we focus on the response to neuroleptic treatment among white, African-American and Hispanic patients suffering from schizophrenia. Our findings suggest that Hispanic patients need lower doses of neuroleptics than white or African- American patients to attain a similar response in the treatment of schizophrenia. Additionally, our study suggests that, if weight is taken to consideration, African-American patients need the same dose of neuroleptics as do white patients in order to attain a similar response in the treatment of schizophrenia. Further studies are suggested to confirm our findings.

AB - Ethnic differences in psychopharmacological treatment have received much attention in the last two decades. Most of the research efforts conducted so far in the field of ethnopsychopharmacology have focused on comparative responses to neuroleptics and lithium between white and Asian-American patients, and on comparative responses to tricyclic antidepressants among white, African-American and Hispanic patients. In this article we focus on the response to neuroleptic treatment among white, African-American and Hispanic patients suffering from schizophrenia. Our findings suggest that Hispanic patients need lower doses of neuroleptics than white or African- American patients to attain a similar response in the treatment of schizophrenia. Additionally, our study suggests that, if weight is taken to consideration, African-American patients need the same dose of neuroleptics as do white patients in order to attain a similar response in the treatment of schizophrenia. Further studies are suggested to confirm our findings.

UR - http://www.scopus.com/inward/record.url?scp=0033019836&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033019836&partnerID=8YFLogxK

U2 - 10.1023/A:1022153403924

DO - 10.1023/A:1022153403924

M3 - Article

C2 - 10392410

AN - SCOPUS:0033019836

VL - 70

SP - 163

EP - 172

JO - Psychiatric Quarterly

JF - Psychiatric Quarterly

SN - 0033-2720

IS - 2

ER -